Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Generic Oxycodone Gets FDA Approval
March 31, 2004

Email
Email
Print
Print
SubscribeSubscribe
News Summary

The Food and Drug Administration's (FDA's) approval of two generic versions of the painkiller oxycodone is expected to significantly lower the cost of the controversial drug -- not only for legitimate patients but individuals who obtain it illegally, the Associated Press reported March 24.

The FDA approved extended-release versions of oxycodone -- the active ingredient in Oxycontin -- from manufacturers Teva Pharmaceuticals and Endo Pharmaceuticals.

The approval requires the companies to include misuse warnings on the packaging and to implement measures to minimize illegal use.

Purdue Pharma, the maker of Oxycontin, has filed patent lawsuits, so a release date for the generic versions has not been set.

The generic drugs fuel the controversy about the misuse of Oxycontin by people who chew, snort, or inject the tablets to achieve a quick and potentially deadly high. But FDA officials said they are required by law to approve generic versions from competitors of effective drugs.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, focused, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post personal requests for help or general promotions for your organization (Get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.